EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Placebo and nocebo effects in gambling disorder pharmacological trials: a meta-analysis

Konstantinos Ioannidis iD, Nathan T M Huneke iD, Jeremy E Solly iD, Guilherme Fusetto Veronesi iD, Charidimos Tzagarakis iD, Valeria Parlatini iD, Samuel J Westwood iD, Cinzia Del Giovane iD, David S Baldwin iD, Jon E Grant iD, Samuele Cortese iD, Samuel R Chamberlain

Acta Neuropsychiatrica · 2025 · 37

DOI: 10.1017/neu.2024.52 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Acta Neuropsychiatrica, online erschienen am 20.11.2024. Verfasst von Konstantinos Ioannidis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK. Hauptthemen laut MEDLINE: Nocebo Effect, Gambling, Placebo Effect. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Placebo and nocebo effects are widely reported across psychiatric conditions, yet have seldom been examined in the context of gambling disorder. Through meta-analysis, we examined placebo effects, their moderating factors, and nocebo effects, from available randomised, controlled pharmacological clinical trials in gambling disorder.

Methods

We searched, up to 19 February 2024, a broad range of databases, for double-blind randomised controlled trials (RCTs) of medications for gambling disorder. Outcomes were gambling symptom severity and quality of life (for efficacy), and drop outs due to medication side effects in the placebo arms.

Results

We included 16 RCTs ( n = 833) in the meta-analysis. The overall effect size for gambling severity reduction in the placebo arms was 1.18 (95%CI 0.91–1.46) and for quality of life improvement was 0.63 (0.42-0.83). Medication class, study sponsorship, trial duration, baseline severity of gambling and publication year significantly moderated effect sizes for at least some of these outcome measures. Author conflict of interest, placebo run-in, gender split, severity scale choice, age of participants or unbalanced randomisation did not moderate effect sizes. Nocebo effects leading to drop out from the trial were observed in 6% of participants in trials involving antipsychotics, while this was less for other medication types.

Conclusion

Placebo effects in trials of pharmacological treatment of gambling disorder are large, and there are several moderators of this effect. Nocebo effects were measureable and may be influenced by medication class being studied. Practical implications of these new findings for the field are discussed, along with recommendations for future clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nocebo EffectGamblingPlacebo EffectHumansRandomized Controlled Trials as TopicQuality of Life

Stichwörter der Autor:innen

Gamblingmeta-analysispharmacotherapyplacebotreatment

Autor:innen und Institutionen

  • Department of Psychiatry, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK.
  • Hampshire and Isle of Wight Healthcare NHS Foundation Trust, Southampton, UK.
  • Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Department of Psychiatry, University of Cambridge, UK.
  • Department of Psychiatry, School of Medicine, University of Crete, Iraklion, Greece.
  • Organization Against Drugs (OKANA), Athens, Greece.

ORCID-Profile: Konstantinos Ioannidis, Nathan T M Huneke, Jeremy E Solly, Guilherme Fusetto Veronesi, Charidimos Tzagarakis, Valeria Parlatini, Samuel J Westwood, Cinzia Del Giovane, David S Baldwin, Jon E Grant, Samuele Cortese

Zitieren

APA

Ioannidis, K., Huneke, N. T. M., Solly, J. E., Fusetto Veronesi, G., Tzagarakis, C., Parlatini, V., Westwood, S. J., Del Giovane, C., Baldwin, D. S., Grant, J. E., Cortese, S., & Chamberlain, S. R. (2025). Placebo and nocebo effects in gambling disorder pharmacological trials: a meta-analysis. Acta Neuropsychiatrica, 37. https://doi.org/10.1017/neu.2024.52

Vancouver

Ioannidis K, Huneke NTM, Solly JE, Fusetto Veronesi G, Tzagarakis C, Parlatini V, et al. Placebo and nocebo effects in gambling disorder pharmacological trials: a meta-analysis. Acta Neuropsychiatrica. 2025;37. doi:10.1017/neu.2024.52

BibTeX
@article{Ioannidis2025,
  author = {Ioannidis, Konstantinos and Huneke, Nathan T M and Solly, Jeremy E and Fusetto Veronesi, Guilherme and Tzagarakis, Charidimos and Parlatini, Valeria and Westwood, Samuel J and Del Giovane, Cinzia and Baldwin, David S and Grant, Jon E and Cortese, Samuele and Chamberlain, Samuel R},
  title = {Placebo and nocebo effects in gambling disorder pharmacological trials: a meta-analysis},
  journal = {Acta Neuropsychiatrica},
  year = {2025},
  volume = {37},
  doi = {10.1017/neu.2024.52}
}
Kostenlos starten →